Lv1
20 积分 2026-04-27 加入
The global burden of lymphoma: estimates from the Global Burden of Disease 2019 study
11小时前
待确认
115 | THE BTK DEGRADER BGB‐16673 AND THE BCL2 INHIBITOR SONROTOCLAX SHOWS ANTI‐TUMOR ACTIVITY AS SINGLE AGENTS AND IN COMBINATION IN MARGINAL ZONE LYMPHOMA MODELS
22天前
已完结
Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma
27天前
已完结
METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth
28天前
已完结
Enhanced antitumoral activity of the academic CAR-T ARI0002h against normal and low BCMA-expressing myeloma cells after incorporating a transmembrane CD28 domain
28天前
已完结
Zanubrutinib enhances CD19 CAR T killing of B-cell lymphoma by inhibiting BTK phosphorylation, regulating PI3K/AKT/mTOR pathway, and promoting autophagy
28天前
已完结
BCL-2 in leukemia: Enhancing clinical utility
1个月前
已完结
A Phase I Study of Copanlisib and Venetoclax in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
1个月前
已完结
Proteasome-guided haem signalling axis contributes to T cell exhaustion
3个月前
已完结
皖公网安备34019202002308
